期刊文献+

儿童节细胞神经母细胞瘤血清特异性蛋白的筛选与鉴定 被引量:2

Detection and identification of serum biomarker for ganglioneuroblastoma in children
下载PDF
导出
摘要 目的构建更为完善的儿童节细胞神经母细胞瘤(GNB)的早期诊断血清蛋白质指纹图谱模型。方法入选30例GNB术前患儿及30例正常对照儿童,采集血清标本;以弱阳离子交换磁珠芯片(MB-WCX)处理血清,用表面增强激光解析电离飞行时间质谱(SELDI-TOF-MS)筛选方法检测和分析蛋白m/z峰值,筛选特异性蛋白,通过基质辅助激光解析电离飞行时间质谱(MALDI-TOF/TOF)方法对特异性蛋白进行鉴定。结果 SELDI-TOF-MS质谱筛选GNB术前患儿与正常对照儿童得到m/z峰位于5 920的蛋白标记物,该标记物在GNB术前患儿中高表达(6 180.6±2 328.0),相比正常对照儿童(419.1±493.3),差异有统计学意义(P<0.05);经MALDI-TOF/TOF鉴定,该蛋白标记物为类载脂蛋白C-Ⅲ(Apo C-Ⅲ)。结论 m/z峰位于5 920的蛋白标记物考虑为儿童GNB特异性标记物,其有助于儿童GNB的早期诊断。 Objective To build a more perfect serum protein fingerprint models for early diagnosis of ganglioneuroblastoma(GNB) in children.Methods Thirty children with GNB and 30 normal control children were recruited.Serum samples were collected.Nonspecific serum protein was detected and studied by MB-WCX processing,SELDI-TOF-MS mass spectrometry system and MALDI-TOF/TOF platform.Results Through the SELDL-TOX-MS processing,a peak at 5920 m/z protein markers,and the expression of the markers was high in GNB children(6180.6±2328),compared with normal control children(419.1±493.3),the difference was statistically significant(P〈0.05); MALDI-TOF/TOF platform showed that the protein with a peak at 5920 m/z is identified as Apo C- Ⅲ.Conclusions m/z peak of 5920 protein is suggested as specific biomarker of GNB in children,can provide significant reference for early diagnosis of ganglioneuroblastoma,and prognostic monitoring.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2016年第2期124-127,共4页 Journal of Clinical Pediatrics
基金 国家自然科学基金资助项目(No.81172085)
关键词 节细胞神经母细胞瘤 蛋白质组学 类载脂蛋白C-Ⅲ 儿童 ganglioneuroblastoma proteomics apolipoprotein C-Ⅲ child
  • 相关文献

参考文献3

二级参考文献37

  • 1Wang CS,McConathy WJ,Kloer HU,et al.Modulation of lipoprotein lipase activity by apolipoproteins.Effect of apolipoprotein C-Ⅲ[J].J Clin Invest,1985,75:384-390.
  • 2McConathy WJ,Gesquiere JC,Bass H,et al.Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-Ⅲ[J].Lipid Res,1992,33(7):995-1003.
  • 3Grundy SM.Atlas of Atherosclerosis:Risk Factors and Treatment,Current Medicine[M].Philadelphia,PA:Current Medicine,LLC,2005.
  • 4Schaap FG,Nierman MC,Berbée JF,et al.Evidence for a complex relationship between apoA-V and apoC-Ⅲ in patients with severe hypertriglyceridemia[J].J Lipid Res,2006,47:2333-2339.
  • 5Chan DC,Watts GF,Nguyen MN,et al.Apolipoproteins C-Ⅲ and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics[J].Arterioscler Thromb Vasc Biol,2006,26:590-596.
  • 6Gerritsen G,Rensen PC,Kypreos KE,et al.ApoC-Ⅲ deficiency prevents hyperlipidemia induced by apoE overexpression[J].Lipid Res,2005,46:1466-1473.
  • 7von Eckardstein A,Holz H,Sandkamp M,et al.ApolipoproteinC-Ⅲ(Lys58→Glu).Identification of an apolipoprotein C-Ⅲ variant in a family with hyperαlipoproteinemia[J].J Clin Invest,1991,87:1724-1731.
  • 8Chan DC,Watts GF,Barrett PHR,et al.Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity[J].Clin Chem,2002,48:278-283.
  • 9Nguyen MN,Chan DC,Dwyer KP,et al.Use of intralipid for kinetic analysis of HDL apoC-Ⅲ:evidence for a homogeneous kinetic pool of apoC-Ⅲ in plasma[J].Lipid Res,2006,47:1274-1280.
  • 10Takahashi T,Hirano T,Okada K,et al.Apolipoprotein CⅢ deficiency prevents the development of hypertriglyceridemia in streptozotocin-induced diabetic mice[J].Metab Clin Exp,2003,52:1354-1359.

共引文献14

同被引文献22

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部